Compound treats psoriasis, may curb autoimmune diseases, researchers say
A compound from immune cells treats psoriasis in mice and might also be effective in treating multiple sclerosis, rheumatoid arthritis and lupus.
Brain blamed for male mice gaining more weight than females
Researchers have determined why they believe men traditionally gain more weight than women — and the answer likely involves the brain, according to a study.
Class of type 2 diabetes drugs doesn’t cut death risk compared to placebo
Comparing three classes of type 2 diabetes drugs, researchers found one class, which includes Onglyza and Januvia, did not reduce death risk.
Gene mapping can help doctors pick most appropriate chemotherapy
Researchers have devised a new gene mapping technique that allows medical providers to determine the chemotherapy with the fewest side effects and best success.
Four in 10 Americans live in areas with unhealthy air, report says
About 133.9 million people — roughly one fifth of all Americans — were living in counties with unhealthy levels of ozone or particle pollution from 2014-2016.
FDA approves Opdivo, Yervoy combination for kidney cancer
The Food and Drug Administration has approved a combination of two immunotherapy drugs, ipilimumab and nivolumab, to treat metastatic kidney cancer.
FDA staff backs epilepsy drug made from cannabis plant
Staff at the FDA have approved an experimental drug made from a marijuana plant used to treat children with two rare forms of epilepsy.
Kids bombarded with junk-food advertising, research finds
Children were exposed to twice as much unhealthy food advertising as healthy food ads, according to a study conducted in Australia.
Drug-reminder app didn’t improve blood pressure, study finds
A smartphone app with a reminder significantly improved medication use among adults with hypertension, but did not help improve blood pressure results.
Study: Drug, chemo combo double survival in metastatic lung cancer
Combining the immunotherapy drug pembrolizumab with chemotherapy doubles survival in patients with some forms of lung cancer compared with chemo alone.
